Veterinary virologists get $3.7M grant for COVID researchAugust 30, 2021A five-year, $3.7-million grant supporting the research of a new COVID treatment has been issued to veterinary virologists at Kansas State University (K-State).
SPONSORED CONTENTTest Match: Two Anti-Itch Drugs Face OffReducing pruritis is critical to enhancing quality of life for both patients and their people, hence the ongoing search for effective treatments. Ilunocitinib, a recently FDA-approved Janus kinase inhibitor, gave a powerful performance in a head-to-head match-up with Apoquel®. +
Ending pet obesity drives academic, corporate collaborationDecember 1, 2020Improving the health of animals by eliminating pet obesity is the primary focus of a significant renovation at the Kansas State University (K-State) College of Veterinary Medicine teaching hospital.
Are veterinary virologists on cusp of COVID treatment?August 5, 2020Newly published NIH-funded research demonstrates small molecule protease inhibitors show potency against human coronaviruses.
Feed additives could mitigate the spread of deadly ASFJuly 7, 2020Feed additives might be the key to controlling a rapidly spreading animal virus that is killing the world’s pig population and threatening human food security.
$11.3M grant strengthens attack against zoonotic diseaseJune 2, 2020A team of Kansas State University (K-State) veterinary researchers have received a five-year, $11.3-million grant from the National Institutes of Health (NIH).
K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
Active bats raise red alertSeptember 17, 2019With an active bat season approaching, a clinical professor from Kansas State University (K-State) is reminding veterinarians and owners to remain vigilant in protecting pets against rabies.
